{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:32:06Z","timestamp":1791444726547,"version":"4.3.3"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["G1801219"],"award-info":[{"award-number":["G1801219"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ebiom.2026.106198","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T05:42:36Z","timestamp":1772862156000},"page":"106198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Serological and faecal markers of irritable bowel syndrome: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"126","author":[{"given":"Grace L.","family":"Burns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6505-2559","authenticated-orcid":false,"given":"Freya","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8793-7141","authenticated-orcid":false,"given":"Jasmine A.","family":"Wark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerith","family":"Duncanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Talley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1248-9590","authenticated-orcid":false,"given":"Simon","family":"Keely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","article-title":"The functional gastrointestinal disorders and the Rome III process","volume":"130","author":"Drossman","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12916-022-02301-8","article-title":"Immune responses in the irritable bowel syndromes: time to consider the small intestine","volume":"20","author":"Burns","year":"2022","journal-title":"BMC Med"},{"issue":"23","key":"10.1016\/j.ebiom.2026.106198_bib3","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1113\/JP281620","article-title":"Physiological mechanisms of unexplained (functional) gastrointestinal disorders","volume":"599","author":"Burns","year":"2021","journal-title":"J Physiol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106198_bib4","first-page":"613","article-title":"Current and future biomarkers in colorectal cancer","volume":"30","author":"Zarkavelis","year":"2017","journal-title":"Ann Gastroenterol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.trsl.2012.01.001","article-title":"Biomarkers in inflammatory bowel disease: current practices and recent advances","volume":"159","author":"Iskandar","year":"2012","journal-title":"Transl Res"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106198_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/apt.12608","article-title":"A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads","volume":"39","author":"Jones","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib8","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2011.03.023","article-title":"The search for biomarkers and endophenotypes in functional gastrointestinal disorders","volume":"140","author":"Mayer","year":"2011","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib9","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1053\/j.gastro.2014.03.028","article-title":"Diagnosing irritable bowel syndrome with a combination of biomarkers and psychomarkers","volume":"146","author":"Sood","year":"2014","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106198_bib10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/apt.13351","article-title":"Review article: biomarkers and personalised therapy in functional lower gastrointestinal disorders","volume":"42","author":"Camilleri","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106198_bib11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/2041-210X.13118","article-title":"Reproducible, flexible and high-throughput data extraction from primary literature: the metaDigitise r package","volume":"10","author":"Pick","year":"2019","journal-title":"Methods Ecol Evol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12874-024-02356-6","article-title":"Meta-analysis accelerator: a comprehensive tool for statistical data conversion in systematic reviews with meta-analysis","volume":"24","author":"Abbas","year":"2024","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ebiom.2026.106198_bib13","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 65","article-title":"Chapter 6: choosing effect measures and computing estimates of effect","author":"Higgins","year":"2024"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106198_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting Meta-Analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106198_bib15","article-title":"Standardized mean differences in meta-analysis: a tutorial","volume":"2","author":"Gallardo-G\u00f3mez","year":"2024","journal-title":"Cochrane Evid Synth Methods"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106198_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3102\/10769986030003261","article-title":"Bias and efficiency of meta-analytic variance estimators in the random-effects model","volume":"30","author":"Viechtbauer","year":"2005","journal-title":"J Educ Behav Stat"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106198_bib17","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106198_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jrsm.11","article-title":"Outlier and influence diagnostics for meta-analysis","volume":"1","author":"Viechtbauer","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.ebiom.2026.106198_bib19","series-title":"Regression methods to detect publication and other bias in meta-analysis","first-page":"99","author":"Sterne","year":"2005"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106198_bib20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/jalm\/jfac069","article-title":"Comparison of high-sensitivity C-Reactive protein vs C-reactive protein for cardiovascular risk prediction in chronic cardiac disease","volume":"7","author":"Han","year":"2022","journal-title":"J Appl Lab Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12876-024-03373-x","article-title":"Overweight and vitamin D deficiency are common in patients with irritable bowel syndrome - a cross-sectional study","volume":"24","author":"Roth","year":"2024","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib22","first-page":"259","article-title":"Evaluation of Gut Microbiota variations and its relationship with Interleukin-6 and \u03b2-Defensin-2 in patients with irritable bowel syndrome","volume":"34","author":"Mohamed","year":"2025","journal-title":"Egypt J Med Microbiol"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106198_bib23","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00109-025-02558-5","article-title":"Serum proteins and faecal microbiota as potential biomarkers in newly diagnosed, treatment-naive inflammatory bowel disease and irritable bowel syndrome patients","volume":"103","author":"Matijasic","year":"2025","journal-title":"J Mol Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/s12876-024-03509-z","article-title":"Anti-CdtB and Anti-vinculin antibodies to diagnose irritable bowel syndrome in inflammatory bowel disease patients","volume":"24","author":"Barros","year":"2024","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106198_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4103\/joah.joah_64_25","article-title":"The role of Hemogram parameters and systemic inflammatory biomarkers (C-Reactive Protein, Erythrocyte Sedimentation Rate, Interleukin-6, Tumor Necrosis Factor Alpha) in the pathophysiology and diagnosis of irritable bowel syndrome","volume":"16","author":"Al-Shammari","year":"2025","journal-title":"J Appl Hematol"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106198_bib26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.14715\/cmb\/2025.71.9.10","article-title":"Bitter frankincense water modulates hepatic enzyme activity in female patients with irritable bowel syndrome","volume":"71","author":"Al-Khafaji","year":"2025","journal-title":"Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14984","article-title":"Elevated fecal biomarkers of colo-rectal epithelial cell activity in irritable bowel syndrome","volume":"37","author":"Venge","year":"2025","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.ebiom.2026.106198_bib28","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.18859","article-title":"Serum salusin levels in diarrhea- and constipation-predominant irritable bowel syndrome","volume":"13","author":"Tuncel","year":"2025","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12664-024-01525-1","article-title":"Fecal calgranulin as a potential screening tool to differentiate inflammatory bowel disease from irritable bowel syndrome","volume":"43","author":"Kumar","year":"2024","journal-title":"Indian J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106198_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2274128","article-title":"Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: a potential clinically relevant stratification factor based on catabotyping analysis","volume":"15","author":"Gargari","year":"2023","journal-title":"Gut Microbes"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106198_bib31","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1365-2222.2007.02727.x","article-title":"Alterations of food antigen-specific serum immunoglobulins G and E antibodies in patients with irritable bowel syndrome and functional dyspepsia","volume":"37","author":"Zuo","year":"2007","journal-title":"Clin Exp Allergy"},{"issue":"13","key":"10.1016\/j.ebiom.2026.106198_bib32","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1097\/CM9.0000000000000306","article-title":"Effect of the interleukin 10 polymorphisms on interleukin 10 production and visceral hypersensitivity in Chinese patients with diarrhea-predominant irritable bowel syndrome","volume":"132","author":"Zhu","year":"2019","journal-title":"Chin Med J"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib33","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.3892\/mmr.2015.4079","article-title":"Imbalance of tumor necrosis factor-\u03b1, interleukin-8 and interleukin-10 production evokes barrier dysfunction, severe abdominal symptoms and psychological disorders in patients with irritable bowel syndrome-associated diarrhea","volume":"12","author":"Zhen","year":"2015","journal-title":"Mol Med Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106198_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13741","article-title":"Peroxiredoxin 1 as an inflammatory marker in diarrhea-predominant and postinfectious irritable bowel syndrome","volume":"32","author":"Zhang","year":"2020","journal-title":"Neurogastroenterol Motil"},{"issue":"43","key":"10.1016\/j.ebiom.2026.106198_bib35","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.3748\/wjg.v25.i43.6416","article-title":"Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome","volume":"25","author":"Zhang","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106198_bib36","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1007\/s10620-016-4136-z","article-title":"B cell-activating factor as a new potential marker in inflammatory bowel disease","volume":"61","author":"Zhang","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106198_bib37","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.3748\/wjg.v22.i12.3451","article-title":"Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis","volume":"22","author":"Yu","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/003693300505000111","article-title":"The urinary 5-hydroxyindole acetic acid and plasma nitric oxide levels in irritable bowel syndrome: a preliminary study","volume":"50","author":"Yazar","year":"2005","journal-title":"Scott Med J"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10620-022-07500-0","article-title":"Significant differences in Gut Microbiota between irritable bowel syndrome with diarrhea and healthy controls in Southwest China","volume":"68","author":"Yao","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ebiom.2026.106198_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.580980","article-title":"Multiomics Study of gut bacteria and host metabolism in irritable bowel syndrome and depression patients","volume":"10","author":"Xu","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106198_bib41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NNR.0000000000000281","article-title":"Serum proteomics in African American female patients with irritable bowel syndrome: an exploratory study","volume":"67","author":"Weaver","year":"2018","journal-title":"Nurs Res"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106198_bib42","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1007\/s10620-022-07543-3","article-title":"Fecal microbiota signatures are not consistently related to symptom severity in irritable bowel syndrome","volume":"67","author":"Wang","year":"2022","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106198_bib43","first-page":"247","article-title":"Role of fecal calprotectin in the diagnosis and treatment of segmental colitis associated with diverticulosis","volume":"57","author":"Tursi","year":"2011","journal-title":"Minerva Gastroenterol Dietol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib44","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/gutjnl-2012-304042","article-title":"Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit","volume":"63","author":"Tooth","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.ebiom.2026.106198_bib45","first-page":"375","article-title":"The propionic acid and butyric acid in serum but not in faeces are increased in patients with diarrhea-predominant irritable bowel syndrome","volume":"34","author":"Tian","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jgh.13598","article-title":"Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease","volume":"32","author":"Thorsvik","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib47","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/MCG.0000000000001896","article-title":"Prevalence of Anti-Saccharomyces Cerevisiae Antibodies (ASCA) in patients with Irritable Bowel Syndrome (IBS). A case-control study","volume":"58","author":"Thomas-Dupont","year":"2023","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106198_bib48","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/apt.13459","article-title":"Alterations in serotonin metabolism in the irritable bowel syndrome","volume":"43","author":"Thijssen","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106198_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14854","article-title":"Fecal bacteria and short-chain fatty acids in irritable bowel syndrome: relations to subtype","volume":"36","author":"Teige","year":"2024","journal-title":"Neurogastroenterol Motil"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106198_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gutjnl-2019-318664","article-title":"Zonulin in serum as a biomarker fails to identify the IBS, functional dyspepsia and non-coeliac wheat sensitivity","volume":"69","author":"Talley","year":"2020","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106198_bib51","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000064","article-title":"Circulating anti-cytolethal distending toxin B and anti-vinculin antibodies as biomarkers in community and healthcare populations with functional dyspepsia and irritable bowel syndrome","volume":"10","author":"Talley","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.ebiom.2026.106198_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35241-6","article-title":"Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects","volume":"8","author":"Sundin","year":"2018","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib53","first-page":"267","article-title":"Immunoregulatory disorders in irritable bowel syndrome","volume":"36","author":"Stankiewicz","year":"2011","journal-title":"Central Eur J Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib54","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1177\/2050640619826419","article-title":"Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D","volume":"7","author":"Singh","year":"2019","journal-title":"United European Gastroenterol J"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib55","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.clinre.2015.12.013","article-title":"Serum immune biomarkers in irritable bowel syndrome","volume":"40","author":"Seyedmirzaee","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106198_bib56","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/MCG.0b013e3181986900","article-title":"Serum Leptin levels and irritable bowel syndrome: a new hypothesis","volume":"43","author":"Semnani","year":"2009","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib57","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/ajg.2011.484","article-title":"Lower serum IL-10 is an independent predictor of IBS among volunteers in Mexico","volume":"107","author":"Schmulson","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib58","first-page":"236","article-title":"Clinical experience with the use of anti-CdtB and anti-vinculin antibodies in patients with diarrhea in Mexico","volume":"81","author":"Schmulson","year":"2016","journal-title":"Rev Gastroenterol Mex"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib59","doi-asserted-by":"crossref","DOI":"10.1186\/s43162-023-00263-8","article-title":"Evaluation of the diagnostic performance of estimated fecal calprotectin and serum intelectin-1 and C-reactive protein solo or in combination for differentiation between patients with query ulcerative colitis and irritable bowel syndrome","volume":"35","author":"Sarhan","year":"2023","journal-title":"Egypt J Intern Med"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106198_bib60","doi-asserted-by":"crossref","first-page":"631","DOI":"10.5152\/tjg.2018.17593","article-title":"Relationship between irritable bowel syndrome and plasma and tissue ghrelin levels","volume":"29","author":"\u015eahin-Ery\u0131lmaz","year":"2018","journal-title":"Turk J Gastroenterol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106198_bib61","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3390\/jcm11071881","article-title":"Measurement of Serum IgG anti-integrin alphavbeta6 autoantibodies is a promising tool in the diagnosis of ulcerative colitis","volume":"11","author":"Rydell","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ebiom.2026.106198_bib62","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1827937","article-title":"Adipose tissue-derived biomarkers of intestinal barrier functions for the characterization of diarrhoea-predominant IBS","volume":"2018","author":"Russo","year":"2018","journal-title":"Dis Markers"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106198_bib63","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1007\/s10620-021-07368-6","article-title":"Correlation between zinc nutritional status with Serum Zonulin and gastrointestinal symptoms in diarrhea-predominant irritable bowel syndrome: a case\u2013control Study","volume":"67","author":"Rezazadegan","year":"2022","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15080-2","article-title":"Zinc nutritional status, mood states and quality of life in diarrhea-predominant irritable bowel syndrome: a case\u2013control study","volume":"12","author":"Rezazadegan","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106198_bib65","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1007\/s10620-017-4585-z","article-title":"Assessment of anti-vinculin and anti-cytolethal distending toxin B antibodies in subtypes of irritable bowel syndrome","volume":"62","author":"Rezaie","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib66","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7869\/tg.2012.66","article-title":"Pro-inflammatory and anti-inflammatory cytokine response in diarrhoea-predominant irritable bowel syndrome patients","volume":"33","author":"Rana","year":"2012","journal-title":"Trop Gastroenterol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ygh2.417","article-title":"A novel distinctive form of identification for differential diagnosis of irritable bowel syndrome, inflammatory bowel disease, and healthy controls","volume":"2","author":"Ramio-Pujol","year":"2020","journal-title":"GastroHep"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106198_bib68","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/gut.52.12.1799-a","article-title":"Platelet activation in patients with irritable bowel syndrome may reflect a subclinical inflammatory response","volume":"52","author":"Qasim","year":"2003","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126438","article-title":"Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects","volume":"10","author":"Pimentel","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106198_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105328","article-title":"Relationship between vagal tone, cortisol, TNF-alpha, epinephrine and negative affects in Crohn's disease and irritable bowel syndrome","volume":"9","author":"Pellissier","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib71","first-page":"21","article-title":"Gut microbiota in mucosa and feces of newly diagnosed, treatment-naive adult inflammatory bowel disease and irritable bowel syndrome patients","volume":"14","author":"Paljetak","year":"2022","journal-title":"Gut Microbes"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106198_bib72","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1515\/CCLM.2008.361","article-title":"Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome","volume":"46","author":"Otten","year":"2008","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib73","first-page":"398","article-title":"Increased TLR2 expression on blood monocytes in irritable bowel syndrome patients","volume":"24","author":"Ohman","year":"2012","journal-title":"Eur J Gastroen Hepat"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106198_bib74","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S1542-3565(05)00410-6","article-title":"A controlled study of colonic immune activity and \u03b27+ blood T lymphocytes in patients with irritable bowel syndrome","volume":"3","author":"\u00d6hman","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ebiom.2026.106198_bib75","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbi.2020.11.035","article-title":"Fatigue in irritable bowel syndrome is associated with plasma levels of TNF-alpha and mesocorticolimbic connectivity","volume":"92","author":"Norlin","year":"2021","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.ebiom.2026.106198_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/srep26420","article-title":"A novel biomarker panel for irritable bowel syndrome and the application in the general population","volume":"6","author":"Mujagic","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib77","doi-asserted-by":"crossref","first-page":"2063016","DOI":"10.1080\/19490976.2022.2063016","article-title":"Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome","volume":"14","author":"Mujagic","year":"2022","journal-title":"Gut Microbes"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106198_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185855","article-title":"Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease","volume":"12","author":"Mortensen","year":"2017","journal-title":"PLoS one"},{"issue":"6 S1","key":"10.1016\/j.ebiom.2026.106198_bib79","doi-asserted-by":"crossref","first-page":"S-364","DOI":"10.1016\/S0016-5085(19)37747-9","article-title":"Second generation anti-CtDB and Anti-vinculin testing produces greater diagnostic accuracy for IBS-D compared to IBD","volume":"156","author":"Morales","year":"2019","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106198_bib80","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.25122\/jml-2022-0089","article-title":"The role of serum gastric peptide ghrelin hormone level in irritable bowel syndrome at Zagazig University Hospitals","volume":"15","author":"Monem","year":"2022","journal-title":"J Med Life"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib81","doi-asserted-by":"crossref","first-page":"585","DOI":"10.51821\/84.4.009","article-title":"Clinical assessment and cytokines level in constipation-predominant irritable bowel syndrome participants treated with lactobacillus-containing cultured milk drink","volume":"84","author":"Mokhtar","year":"2021","journal-title":"Acta Gastroenterol Belg"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106198_bib82","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/2050640616650062","article-title":"Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study","volume":"5","author":"Melchior","year":"2017","journal-title":"United European Gastroenterol J"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106198_bib83","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ueg2.12137","article-title":"Serum L-arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: a nested case-control study","volume":"9","author":"McEvoy","year":"2021","journal-title":"United European Gastroenterol J"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106198_bib84","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3748\/wjg.v23.i3.437","article-title":"\u03b12-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease","volume":"23","author":"Manolakis","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106198_bib85","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.21608\/ejhm.2021.204576","article-title":"Fecal lactoferrin as a diagnostic and prognostic marker in Egyptian ibd patients","volume":"85","author":"Makhlouf","year":"2021","journal-title":"Egypt J Hosp Med"},{"key":"10.1016\/j.ebiom.2026.106198_bib86","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/162517","article-title":"Serum omentin-1 as a disease activity marker for Crohn's disease","volume":"2014","author":"Lu","year":"2014","journal-title":"Dis Markers"},{"issue":"14","key":"10.1016\/j.ebiom.2026.106198_bib87","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1097\/CM9.0000000000002294","article-title":"Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity","volume":"135","author":"Liu","year":"2022","journal-title":"Chin Med J"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib88","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3748\/wjg.v24.i1.46","article-title":"Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome","volume":"24","author":"Liu","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106198_bib89","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2007.01.046","article-title":"Immune activation in patients with irritable bowel syndrome","volume":"132","author":"Liebregts","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib90","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.clinre.2016.12.007","article-title":"Decreased glucagon-like peptide-1 correlates with abdominal pain in patients with constipation-predominant irritable bowel syndrome","volume":"41","author":"Li","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib91","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/00365520510023909","article-title":"Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis","volume":"41","author":"Lettesjo","year":"2006","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106198_bib92","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1365-2036.2009.03975.x","article-title":"Use of serum biomarkers in a diagnostic test for irritable bowel syndrome","volume":"29","author":"Lembo","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106198_bib93","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13830","article-title":"Characteristics of fecal metabolic profiles in patients with irritable bowel syndrome with predominant diarrhea investigated using 1 H-NMR coupled with multivariate statistical analysis","volume":"32","author":"Lee","year":"2020","journal-title":"Neurogastroenterol Motil"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib94","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2982.2008.01220.x","article-title":"Immune dysfunction in patients with functional gastrointestinal disorders","volume":"21","author":"Kindt","year":"2009","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib95","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11745-004-1247-x","article-title":"Fatty acid profile and affective dysregulation in irritable bowel syndrome","volume":"39","author":"Kilkens","year":"2004","journal-title":"Lipids"},{"key":"10.1016\/j.ebiom.2026.106198_bib96","first-page":"84","article-title":"Novel biomarker panel for the irritable bowel syndrome: a diagnostic blood test is promising","volume":"26","author":"Jones","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106198_bib97","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/metabo11090612","article-title":"Concentrations of fecal bile acids in participants with functional gut disorders and healthy controls","volume":"11","author":"James","year":"2021","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106198_bib98","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/metabo13020313","article-title":"Concentrations of plasma amino acids and neurotransmitters in participants with functional gut disorders and healthy controls","volume":"13","author":"James","year":"2023","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib99","first-page":"77","article-title":"Serological levels of cytokines in irritable bowel syndrome (IBS) patients and non-IBS subjects with and without Blastocystis spp. infection","volume":"68","author":"Ismail","year":"2022","journal-title":"Ann Parasitol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106198_bib100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5455\/medarh.2024.78.105-111","article-title":"Role of Calprotectin, IL-6, and CRP in distinguishing between inflammatory bowel disease and diarrhea predominant irritable bowel syndrome","volume":"78","author":"Huong","year":"2024","journal-title":"Med Arch"},{"key":"10.1016\/j.ebiom.2026.106198_bib101","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.2147\/JIR.S458363","article-title":"The neutrophil-to-albumin ratio (NAR): a novel index in relation to clinical symptoms, quality of life, and psychological status in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)","volume":"17","author":"Huang","year":"2024","journal-title":"J Inflamm Res"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106198_bib102","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-2982.2007.00943.x","article-title":"Sigmoid-colonic motility in health and irritable bowel syndrome: a role for 5-hydroxytryptamine","volume":"19","author":"Houghton","year":"2007","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib103","first-page":"9","article-title":"The serum levels of CCL2 and CCL16 expression in patients with irritable bowel syndrome","volume":"8","author":"Hayatbakhsh","year":"2019","journal-title":"Rep Biochem Mol Biol"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106198_bib104","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1365-2982.2010.01568.x","article-title":"Differential responding of autonomic function to histamine H1 antagonism in irritable bowel syndrome","volume":"22","author":"Hattori","year":"2010","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106198_bib105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jgh3.12724","article-title":"No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after Giardia infection","volume":"6","author":"Hanevik","year":"2022","journal-title":"JGH Open"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib106","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41396-021-01123-5","article-title":"Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity","volume":"16","author":"Han","year":"2022","journal-title":"ISME J"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib107","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5152\/tjg.2021.21321","article-title":"Relationship between systemic immune-inflammation index and irritable bowel syndrome","volume":"33","author":"G\u00fcven","year":"2022","journal-title":"Turk J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106198_bib108","first-page":"13","article-title":"The combined performance of fecal calprotectin with fecal occult blood, lymphocyte and neutrophil percentages in discriminating ulcerative colitis","volume":"16","author":"G\u00fcr","year":"2020","journal-title":"Nobel Med J"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106198_bib109","first-page":"8331","article-title":"Correlation between serum neuropeptide Y, substance P, and 5-HT expression and anxiety and depression in constipation-predominant irritable bowel syndrome patients","volume":"11","author":"Guo","year":"2018","journal-title":"Int J Clin Exp Med"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106198_bib110","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3109\/00365529509096344","article-title":"Central 5-hydroxytryptaminergic function in irritable bowel syndrome","volume":"30","author":"Gorard","year":"1995","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib111","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3892\/etm.2013.1101","article-title":"Correlation between anxiety-depression status and cytokines in diarrhea-predominant irritable bowel syndrome","volume":"6","author":"Gao","year":"2013","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib112","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/19490976.2021.1943288","article-title":"A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease","volume":"13","author":"Gacesa","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ebiom.2026.106198_bib113","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1038\/s41598-017-02835-5","article-title":"Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation","volume":"7","author":"Fu","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib114","first-page":"A359","article-title":"Fecal s100a12 as non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome","volume":"132","author":"Foell","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib115","doi-asserted-by":"crossref","first-page":"S660","DOI":"10.1016\/S0016-5085(15)32228-9","article-title":"Fecal Short Chain Fatty Acids (SCFA) - a biomarker for Irritable Bowel Syndrome (IBS)?","volume":"148","author":"Farup","year":"2015","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106198_bib116","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3923\/pjbs.2020.898.903","article-title":"Serum levels of interferon gamma INF-\u03b3 and interleukin 10 il-10: an immunological aspect among irritable bowel syndrome patients","volume":"23","author":"Eltayeb","year":"2020","journal-title":"Pakistan J Biol Sci"},{"key":"10.1016\/j.ebiom.2026.106198_bib117","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000733","article-title":"Fecal and serum granulocyte protein levels in inflammatory bowel disease and irritable bowel syndrome and their relation to disease activity","volume":"15","author":"Ekoff","year":"2024","journal-title":"Clin Transl Gastroenterol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib118","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41564-022-01103-1","article-title":"Gut microbial \u03b2-glucuronidases regulate host luminal proteases and are depleted in irritable bowel syndrome","volume":"7","author":"Edwinson","year":"2022","journal-title":"Nat Microbiol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib119","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s10620-018-5002-y","article-title":"Assessment of serum sTREM-1 as a marker of subclinical inflammation in diarrhea-predominant patients with irritable bowel syndrome","volume":"63","author":"Du","year":"2018","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106198_bib120","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.gastro.2005.11.033","article-title":"Hypothalamic-Pituitary-Gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?","volume":"130","author":"Dinan","year":"2006","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib121","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/00365521.2021.1879247","article-title":"Colonic paracellular permeability and circulating zonulin-related proteins","volume":"56","author":"Meira de-Faria","year":"2021","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106198_bib122","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3390\/nu14091945","article-title":"Diet quality and dietary inflammatory index in Dutch inflammatory bowel disease and irritable bowel syndrome patients","volume":"14","author":"de Graaf","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106198_bib123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093144","article-title":"Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome","volume":"9","author":"Darkoh","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106198_bib124","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1080\/00365520701427094","article-title":"Relationship between fecal lactoferrin and inflammatory bowel disease","volume":"42","author":"Dai","year":"2007","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1590\/1806-9282.63.01.13","article-title":"Alert for bone alterations and low serum concentrations of Vitamin D in patients with intestinal in?ammatory disease","volume":"63","author":"Kotze","year":"2017","journal-title":"Rev Assoc Med Bras"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106198_bib126","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.nutres.2010.09.009","article-title":"Increased serum free tryptophan in patients with diarrhea-predominant irritable bowel syndrome","volume":"30","author":"Christmas","year":"2010","journal-title":"Nutr Res"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib127","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.3390\/ijms25052550","article-title":"The variability of Tryptophan metabolism in patients with mixed type of irritable bowel syndrome","volume":"25","author":"Chojnacki","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"299","key":"10.1016\/j.ebiom.2026.106198_bib128","first-page":"277","article-title":"The role of serotonin in pathogenesis of unclassified irritable bowel syndrome","volume":"50","author":"Chojnacki","year":"2022","journal-title":"Pol Merkur Lekarski"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106198_bib129","first-page":"254","article-title":"Serum patterns of mir-23a and mir-181b in irritable bowel syndrome and colorectal cancer - a pilot study","volume":"20","author":"Chira","year":"2020","journal-title":"Bosn J Basic Med Sci"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106198_bib130","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ajg.2012.38","article-title":"Serum and colonic mucosal immune markers in irritable bowel syndrome (vol 107, pg 262, 2012)","volume":"107","author":"Chang","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106198_bib131","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/JLB.4A0521-228R","article-title":"Elevated F-EDN correlates with mucosal eosinophil degranulation in patients with IBS-A possible association with microbiota?","volume":"111","author":"Casado-Bedmar","year":"2022","journal-title":"J Leukoc Biol"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106198_bib132","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.cgh.2011.07.030","article-title":"Fecal assays detect hypersensitivity to cow's milk protein and gluten in adults with irritable bowel syndrome","volume":"9","author":"Carroccio","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib133","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1515\/tjb-2020-0305","article-title":"Increased vitamin D binding protein levels are associated with irritable bowel syndrome","volume":"46","author":"Borekci","year":"2021","journal-title":"Turkish J Biochemistry"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib134","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/jim-2016-000062","article-title":"Serum ST2 in inflammatory bowel disease: a potential biomarker for disease activity","volume":"64","author":"Boga","year":"2016","journal-title":"J Investig Med"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.25122\/jml-2021-0120","article-title":"Systemic inflammation in the pathogenesis of irritable bowel syndrome associated with obesity","volume":"14","author":"Bilooka","year":"2021","journal-title":"J Med Life"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib136","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1053\/j.gastro.2017.06.051","article-title":"Vasoactive intestinal polypeptide and mast cells regulate increased passage of colonic bacteria in patients with irritable bowel syndrome","volume":"153","author":"Bednarska","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib137","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/gut.42.1.42","article-title":"Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study","volume":"42","author":"Bearcroft","year":"1998","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106198_bib138","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1136\/gutjnl-2019-319281","article-title":"Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity","volume":"69","author":"Barbaro","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib139","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41598-022-05756-0","article-title":"Associations of neurotransmitters and the gut microbiome with emotional distress in mixed type of irritable bowel syndrome","volume":"12","author":"Barandouzi","year":"2022","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106198_bib140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5114\/fmpcr.2020.95311","article-title":"Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters","volume":"22","author":"Aktas","year":"2020","journal-title":"Fam Med Prim Care Rev"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106198_bib141","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1590\/1516-3180.2018.0274161118","article-title":"Vascular endothelial growth factor, endostatin levels and clinical features among patients with ulcerative colitis and irritable bowel syndrome and among healthy controls: a cross-sectional analytical study","volume":"136","author":"Aksoy","year":"2018","journal-title":"Sao Paulo Med J"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106198_bib142","doi-asserted-by":"crossref","first-page":"e58204","DOI":"10.1371\/journal.pone.0058204","article-title":"An investigation of fecal volatile organic metabolites in irritable bowel syndrome","volume":"8","author":"Ahmed","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106198_bib143","first-page":"OC26","article-title":"Evaluation of faecal calprotectin S100A8\/S100A9 levels in patients suffering from irritable bowel syndrome: a cross-sectional study","volume":"18","author":"Ahmed","year":"2024","journal-title":"J Clin Diagn Res"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106198_bib144","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5005\/jp-journals-10018-1411","article-title":"Comparison of fecal calprotectin with different endoscopic scores in the assessment of Ulcerative Colitis (UC) activity and its utility in differentiating IBS from IBD","volume":"13","author":"Acharya","year":"2023","journal-title":"Euroasian J Hepatogastroenterol"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106198_bib145","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00535-013-0919-6","article-title":"Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome","volume":"49","author":"Shulman","year":"2014","journal-title":"J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106198_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103331","article-title":"Cytokines and intestinal epithelial permeability: a systematic review","volume":"22","author":"Meyer","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106198_bib147","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/nmo.12262","article-title":"Reduced E-cadherin expression is associated with abdominal pain and symptom duration in a study of alternating and diarrhea predominant IBS","volume":"26","author":"Wilcz-Villega","year":"2014","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106198_bib148","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8060775","article-title":"Nutritional laboratory markers in malnutrition","volume":"8","author":"Keller","year":"2019","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib149","article-title":"What are the pearls and pitfalls of the dietary management for chronic diarrhoea?","volume":"13","author":"O'Brien","year":"2021","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106198_bib150","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/jgh.16895","article-title":"Review article: albumin and its role in inflammatory bowel disease: the old, the new, and the future","volume":"40","author":"Cameron","year":"2025","journal-title":"J Gastroenterol Hepatol"},{"issue":"11\u201312","key":"10.1016\/j.ebiom.2026.106198_bib151","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/apt.17754","article-title":"Systematic review with meta-analysis: diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults","volume":"58","author":"Dajti","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106198_bib152","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/flgastro-2013-100420","article-title":"Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?","volume":"6","author":"Dhaliwal","year":"2015","journal-title":"Frontline Gastroenterol"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106198_bib153","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/ibd.22917","article-title":"Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease","volume":"18","author":"D'Haens","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib154","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/gutjnl-2012-304066","article-title":"Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation","volume":"63","author":"Vivinus-Nebot","year":"2014","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106198_bib155","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2016.12.039","article-title":"Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta-analysis","volume":"152","author":"Klem","year":"2017","journal-title":"Gastroenterology"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426000800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426000800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:02:27Z","timestamp":1783972947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426000800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":155,"alternative-id":["S2352396426000800"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106198","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serological and faecal markers of irritable bowel syndrome: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106198"}}